New Therapeutic Strategy for Mood Disorders

E-ISSN： 1875-533x|18|28|4284-4298

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.28, 2011-10, pp. : 4284-4298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: New Therapeutic Options for Anxiety and Mood Disorders)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 6, 2014-08 ,pp. : 927-929

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Erythropoietin in Neurological Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

By Castro A. Martinez A.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

GABA and glutamate systems as therapeutic targets in depression and mood disorders

By Kendell Steven F Krystal John H Sanacora Gerrard

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of 5-HT7 Receptors in Mood Disorders

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1109-1117

Bentham Science Publishers

Access to resources Recommend Favorite